$ Value
$0
Shares
80,000
Price
$0
Filed
Apr 7
Insider
Name
VOLL MARK
Title
Chief Financial Officer
CIK
0001207512
Roles
Transaction Details
Transaction Date
2026-04-03
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
117,380
Footnotes
The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units ("RSUs") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed.
Filing Info
VOLL MARK's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-03 | RNXT | A | $0 |
| 2026-03-25 | RNXT | A | $0 |
| 2026-03-20 | RNXT | ▲ | — |
| 2026-03-20 | RNXT | ▲ | — |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-03-25 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |